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dyslipidemia, type 2 diabetes, and hypertension.[12‑14] 
Coronary heart disease is highly preventable in stroke 
patients.[15]
The risk factors for stroke and MI, especially smoking, 
hypertension, and dyslipidemia are highly prevalent 
in Iran, as well.[16‑18] According to projections, stroke 
continues to be the second leading cause of mortality 
worldwide till 2030.[19] Urbanism, increased life 
expectancy, reduction in childbirth, aging and elderly 
population, epidemiological changes, socioeconomic 
status, geographical conditions, and lifestyles such as 
poor diet, stress, and low mobility are the main causes 
INTRODUCTION
Stroke, after myocardial infarction (MI), is the second 
leading reason for mortality in Iran as with many 
countries worldwide.[1‑3] The epidemiology of stroke has 
already been investigated in the American, European, 
African, and Asian countries.[4‑11] No comprehensive 
study has yet investigated the epidemiology of stroke, 
particularly in MI patients, in Iran, one of the largest 
countries in Southwest Asia. Stroke and MI share many 
risk factors, most prevalent of which are smoking, 
Background: The data and determinants of mortality due to stroke in myocardial infarction (MI) patients are unknown. This study 
was conducted to evaluate the differences in risk factors for hospital mortality among MI patients with and without stroke history. 
Materials and Methods: This study was a retrospective, cohort study; 20,750 new patients with MI from April, 2012 to March, 2013 
were followed up and their data were analyzed according to having or not having the stroke history. Stroke and MI were defined based 
on the World Health Organization’s definition. The data were analyzed by logistic regression in STATA software. Results: Of the 
20,750 studied patients, 4293 had stroke history. The prevalence of stroke in the studied population was derived 20.96% (confidence 
interval [CI] 95%: 20.13–21.24). Of the patients, 2537 (59.1%) had ST‑elevation MI (STEMI). Mortality ratio in patients with and 
without stroke was obtained 18.8% and 10.3%, respectively. The prevalence of risk factors in MI patients with and without a stroke is 
various. The adjusted odds ratio of mortality in patients with stroke history was derived 7.02 (95% CI: 5.42–9) for chest pain resistant 
to treatment, 2.39 (95% CI: 1.97–2.9) for STEMI, 3.02 (95% CI: 2.5–3.64) for lack of thrombolytic therapy, 2.2 (95% CI: 1.66–2.91) for 
heart failure, and 2.17 (95% CI: 1.6–2.9) for ventricular tachycardia. Conclusion: With regards to the factors associated with mortality 
in this study, it is particularly necessary to control the mortality in MI patients with stroke history. More emphasis should be placed 
on the MI patients with the previous stroke over those without in the interventions developed for prevention and treatment, and 
for the prevention of avoidable mortalities.
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of the burden of noncommunicable diseases, particularly 
stroke.[20,21]
Because the determinants of stroke in different communities 
are various,[5,21,22] we require knowledge about the risk 
factors and determinants of mortality in a community for 
effective planning and selection of appropriate strategies for 
the prevention and management of stroke and heart attack 
as the most important causes of death.[23,24]
Since no comprehensive study has yet been investigated the 
status and mortality determinants of stroke in MI patients 
in Iran, this study is conducted to determine and compare 
the determinants of mortality due to stroke in MI patients.
MATERIALS AND METHODS
In this retrospective cohort study, the data obtained from the 
MI Registry of Iran’s Cardiovascular Diseases Surveillance 
System were analyzed. Around 20,750 hospitalized patients 
with MI with a new presentation (hospitalized in 540 hospitals) 
between April, 2012 and March, 2013 were enrolled. 
All the patients’ data were entered into a computerized 
retrospective observational data bank. The study was 
approved by the Management Center of Noncommunicable 
Diseases and the Department of Cardiovascular Diseases 
Prevention of Iran’s Ministry of Health and Medical 
Education (approval no. 305/837). The research followed 
the principles of the Declaration of Helsinki; the researchers 
did not conduct any interventions on the patients, and 
an Institutional Review Board approved this research. 
The study protocol was approved by an Independent 
Scientific Review Committee (at Shahid Beheshti University 
Medical of Sciences) (no. 1392‑1‑85‑12129). Inclusion 
criteria were determined according to the World Health 
Organization (WHO) and World Heart Federation definition 
of MI diagnosis per the International Classification of 
Diseases‑10 codes I21 and I22.[1]
Patients with MI history or no definite diagnosis by a 
cardiologist were excluded from the study. The data 
on age, gender, education, ischemic heart disease 
symptoms, hospital stay duration, smoking, dyslipidemia, 
hypertension, type 2 diabetes, heart failure, and family 
history of cardiovascular diseases were gathered. Stroke 
history was defined based on the WHOs definition “rapidly 
developing signs of focal (or global) disturbance of cerebral 
function lasting >24 h (unless interrupted by surgery or 
death), with no apparent nonvascular cause.” Therefore, 
patients with transient cerebral ischemia or stroke events 
were excluded if they had blood disease or brain tumors. 
Moreover, patients with secondary strokes caused by 
trauma, acute hemorrhagic stroke, or transient ischemic 
attack were excluded.[10,25] After a definite diagnosis of MI 
by a cardiologist, the data on the left bundle branch block, 
right bundle branch block, atrial fibrillation, ventricular and 
atrial tachycardia, type and site of MI, and use of therapeutic 
regimens such as coronary artery bypass grafting, 
percutaneous coronary intervention, and thrombolytic 
therapy were recorded.
Statistical analysis
The cohort of patients was defined by the date at MI 
diagnosis, hospital stay, and follow‑up till discharge 
or death (outcome). Hospital mortality due to MI was 
considered a dependent variable. Odds ratio (OR) of 
mortality for clinical and demographic risk factors were 
calculated by logistic regression. OR of mortality was 
calculated as the crude and adjusted ratio for patients 
with and without stroke by simple and multiple logistic 
regression models. First, univariate analysis was conducted. 
To control confounders, we entered the significant or 
approximately significant variables into a multiple 
regression model. For data analysis, Chi‑square, t‑test, and 
regression model in Stata software (Stata Corp. 2011, Stata 
Statistical Software: Release 14, College Station, TX: Stata 
Corp LP, USA) were used and P < 0.05 was considered the 
level of significance.
RESULTS
Of the 20,750 studied patients with MI, 4293 had a 
stroke history. The prevalence of stroke in the studied 
population was derived 20.96% (confidence interval 
CI 95%: 20.13–21.24). Mean standard deviation age at MI 
incidence was 64.38 (12.9) years in patients with stroke 
history and 60.37 (13.3) years in patients without, with 
a significant difference (P < 0.001). Half of the patients 
with stroke history had 30–64‑year‑old. About 43.6% of 
them had 65–84‑year‑old and 5.4% 85–106. About 64.8% 
of these patients were male, 52.8% of them were illiterate, 
and only 4.9% had an academic education. The prevalence 
of smoking was derived 23.9% in them. The prevalence 
of diabetes, hypertension, hypercholesterolemia, and 
heart failure was obtained 30%, 56.5%, 27.3%, and 8.1% in 
patients with stroke history and 20.1%, 30%, 15.4%, and 
8% in patients without stroke history, respectively. The 
ratio of cardiovascular surgery, percutaneous coronary 
intervention, and thrombolytic therapy was obtained 
6.4%, 5.8%, and 41.1% in the former group and 1.6%, 7.1%, 
and 45.3% in the latter, respectively. The demographic 
characteristics and individual risk factors in patients with 
and without stroke are shown in Table 1.
Within 1 year of study, 18.8% of the stroke patients deceased. 
The mortality ratio in all patients was derived 12.1%. Of the 
4293 patients with stroke, 2537 (59.1%) had ST‑elevation 
MI (STEMI). Mortality ratio was obtained 18.8% in patients 
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stroke history and 10.3% in the without. The clinical 
characteristics and risk factors in the patients according to 
the type of hospital diagnosis and therapeutic measures 
are shown in Table 2. The ratio of cardiovascular surgery, 
percutaneous coronary intervention, and thrombolytic 
therapy was obtained, respectively, 6.4%, 5.8%, and 41.1%. 
By logistic regression, the mortality‑associated factors 
were different in the MI patients with and without stroke 
history. The OR of the studied factors is shown in Table 3. 
The adjusted OR of mortality in patients with stroke history 
was derived 7.02 (95% CI: 5.42–9) for chest pain resistant 
to treatment, 2.39 (95% CI: 1.97–2.9) for STEMI, 3.02 (95% 
CI: 2.5–3.64) for lack of thrombolytic therapy, 2.2 (95% 
CI: 1.66–2.91) for heart failure, and 2.17 (95% CI: 1.6–2.9) 
for ventricular tachycardia. Considering other potential 
covariates and the confounders of hospital mortality in 
patients with stroke, we obtained the highest adjusted OR 
of hospital mortality in patients with stroke for chest pain 
resistant to treatment followed by lack of thrombolytic 
therapy and STEMI.
DISCUSSION
In this study, the risk factors in the MI patients with and 
without stroke history were investigated and compared for 
the first time in Iran. In reliable, electronic databases such 
as PubMed and Scopus, we found no study to model and 
compare the characteristics of the two groups of patients 
as with our study. Our study indicated that the pattern of 
determinants of hospital MI mortality with and without a 
stroke is various. The mean age at incidence in our study 
is similar to a study in Singapore comparing the risk 
factors for stroke in Chinese, Indian, and Malaysian ethnic 
populations. The study in Singapore reported the mean age 
of stroke patients to be 64.1 years. In the study of Singapore, 
hypertension and hypercholesterolemia were found to be the 
most prevalent risk factors. The prevalence of hypertension 
was obtained 83.2%, 85%, and 84.1% in Chinese, Malaysian, 
and Indian ethnics, respectively, which is twice higher than 
the prevalence of hypertension in the patients in Iran.[10,11] 
Moreover, the prevalence of smoking was obtained 11.8%, 
20%, and 15.9% in Chinese, Malaysian, and Indian ethnics 
in Singapore, respectively. The prevalence of smoking was 
obtained approximately 24% in our study, which is higher 
than that reported by the study of Singapore. In the study 
of Singapore, the prevalence of diabetes was reported to be 
67.5% in Malaysian ethnics and 39.8% in Chinese ethnics 
while it was 27.9% in the patients of our study. Within 1 year 
of study, hospital mortality was obtained 9.1%, 3.4%, and 
2.5% in Indian, Chinese, and Malaysian ethnics, respectively. 
The corresponding figure was obtained 32% in the patients 
of our study. This inconsistency can be explained by the 
difference in lifestyles, life expectancy, and the incidence 
of stroke risk factors. Another explanation can be related 
to access to therapeutic and hospital services to prevent 
mortality due to stroke. However, it is noteworthy that the 
sample size in the study of Singapore seems unsatisfactorily 
small, which might be another reason for the inconsistency 
of the findings.[11]
A review article reported that the age at stroke incidence 
was 68.6 years in men and 72.9 years in women, and the 
incidence and prevalence of stroke were higher in men 
than women. Although the age of incidence in our study 
is younger than the age reported in this review article, the 
gender differences in our study and this review article 
Table 1: Demographic and medical history of myocardial infarction patients with and without stroke
Characteristic Total (%) With stroke Without 
stroke
P
Sample size 20,750 4293 (20.69) 16,457 (79.31) ‑
Age (mean±SD) (years) 61.2±13.4 64.38±12.9 60.37±13.9 0.001*
Hospital stay (days) 6.5±14.6 6.5±14.3 6.5±14.6 0.805
Gender
Men 15,033 (72.4) 2784 (64.8) 12,249 (74.5) 0.001*
Women 5717 (27.6) 1509 (35.2) 4208 (25.5)
Education
Illiteracy 9611 (46.3) 2269 (52.8) 7342 (44.6) 0.001*
Primary 4941 (23.8) 963 (22.4) 3978 (24.1)
Guidance 1940 (9.3) 339 (7.9) 1601 (9.7)
High school 2992 (14.4) 511 (11.9) 2481 (15)
University 1266 (6.1) 211 (4.9) 1055 (6.4)
Smoker 5443 (26.2) 1302 (30.3) 4141 (25.16) 0.001*
Diabetes 4612 (22.2) 1290 (30) 3322 (20.1) 0.001*
Hypertension 7376 (35.5) 2425 (56.5) 4951 (30) 0.001*
High cholesterol 3710 (17.8) 1174 (27.3) 2536 (15.4) 0.001*
Heart failure 1682 (8.1) 351 (8.1) 1331 (8) 0.850
Family history of cardiovascular disease 7179 (34.6) 1446 (33.6) 5733 (34.8) 0.157
*P<0.05 considered significant. SD=Standard deviation
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are consistent.[26,27] The prevalence of stroke in our study 
was 20.96% higher than Japanese patients. A nationwide 
multicenter cooperative cohort study of Japanese patients 
with MI and stroke reported stroke history (14.7%) to be 
more frequent than MI history (2.6%) in patients with 
stroke, whereas stroke history (6.6%) was less frequent 
than MI history (7.6%) in patients with MI.[28] The mean 
age at MI incidence in our study is lower than a study in 
Australia that reported the mean age of patients with stroke 
was 78.6 years. The difference in lifestyle, life expectancy, 
and patterns of risk factors for noncommunicable diseases 
as well as the larger elderly population of Australia can be 
some reasons for the discrepancy in the mean age at the 
incidence of stroke. In a study in Nigeria, the prevalence of 
hypertension and dyslipidemia was reported to be 69.4% 
and 21.1%, respectively. The difference in the population 
and environment of the study may be the main reasons for 
the inconsistency of the findings.[5] In a study in Australia 
and Europe (Finland, Norway, Belgium, France, Germany, 
the Netherlands, Switzerland, Italy, Greece, and Hungary), 
3944 patients with stroke were studied, and smoking, 
dyslipidemia, and hypertension were reported to be the 
most prevalent (48.7%, 45.8%, and 35.9%, respectively) risk 
factors for stroke, which are, except hypertension, higher 
than our study. The prevalence of diabetes and heart failure 
in the study in Europe was obtained 6.5–11.1% and 3.8–4.2%, 
respectively,[12] which is lower than the corresponding 
figures in our study. The study in Europe has recommended 
that adoption of a primary strategy to avoid a stroke in 
young adolescents and the intervention aimed to change 
and/or decrease the highly prevalent risk factors that can 
be mitigated is an important principle of the stroke control. 
In Brazil, the risk factors for stroke were studied, and the 
prevalence of hypertension, diabetes, and stroke history was 
reported to be 29.9%, 9.1%, and 2.1%, respectively, which 
are lower than the present study.[29] In a study in Japan, 1389 
incidence of stroke were registered from 1988 to 2004. The 
mean age at incidence was 73.3 years in men and 76.8 years 
in women. Moreover, the prevalence of hypertension, 
diabetes, dyslipidemia, smoking, and heart attack was 55%, 
19.3%, 17.9%, 25.9%, and 6.9%, respectively.[30] In another 
study in Japan, the fatality rate due to stroke was obtained 
14.9% and 15.7% in men and women, respectively. Since life 
expectancy is much higher in Japan than Iran and the mean 
age at stroke incidence is expected to be younger in Iran than 
Japan, the determinants of hospital mortality in our study 
are similar to a study reporting that MI history, diabetes, 
gender, and age are the most common determinants 
of outcome in intracerebral hemorrhage patients.[30] 
Interestingly, the prevalence of risk factors in the MI patients 
without stroke in Iran and Japan is similar. The prevalence of 
manageable risk factors is being controlled in patients with 
stroke and MI and was obtained lower compared to other 
studies. In a review article, the fatality rate of stroke within 
a month after the onset of the disease was reported to be 
17% in Japan, 33% in Italy, and 22.9% overall. The fatality 
of stroke has been derived 32.1%, which is higher than Italy. 
The difference may be explained by the access to better 
therapeutic services in hospitals and health‑care facilities 
Table 2: Prevalence of clinical risk factors in myocardial 
infarction patients with and without stroke
Characteristic Total (%) With 
stroke
Without 
stroke
P
AF 511 (2.5) 203 (4.7) 485 (2.9) 0.001
VT 1198 (5.8) 277 (6.4) 921 (5.6) 0.032
RBBB 289 (1.4) 81 (1.8) 208 (1.2) 0.002
LBBB 383 (1.8) 160 (3.7) 223 (1.3) 0.001
Lateral MI 990 (4.8) 228 (5.3) 762 (4.6) 0.062
Anterior MI 4332 (20.9) 789 (18.3) 3543 (21.5) 0.001
Inferior MI 7179 (34.6) 1446 (33.6) 5733 (34.8) 0.157
Posterior MI 853 (4.2) 143 (3.3) 710 (4.3) 0.004
STEMI 15,729 (75.8) 2537 (59.1) 10,568 (64.2) 0.001
Death 2511 (12.1) 808 (18.8) 1703 (10.3) 0.001
PCI 1431 (6.9) 252 (5.8) 1179 (7.1) 0.003
CABG 539 (2.6) 275 (6.4) 264 (1.6) 0.001
Lack of thrombolytic 
therapy
9222 (44.5) 1767 (41.1) 7455 (45.3) 0.001
Chest pain 2229 (10.7) 401 (9.3) 1828 (11.1) 0.001
AF=Atrial fibrillation; VT=Ventricular tachycardia; RBBB=Right bundle branch block; 
LBBB=Left bundle branch block; MI=Myocardial infarction; STEMI=ST‑segment 
elevation myocardial infarction; NSTEMI=Non‑ST‑segment elevation myocardial 
infarction; PCI=Percutaneous coronary intervention; CABG=Coronary artery 
bypass grafting
Table 3: Risk factors for hospital mortality in myocardial 
infarction patients with and without stroke
Characteristics With Stroke Without Stroke
OR CI P OR CI P
Standardized 
age (year)
1.52 1.36‑1.69 0.001 1.47 1.38‑1.58 0.001
Women 1.26 1.03‑1.53 0.019 1.21 1.06‑1.38 0.003
Education
Illiterate 0.82 0.53‑1.27 0.385 0.84 0.65‑1.08 0.180
Primary 0.70 0.45‑1.10 0.125 0.76 0.59‑0.98 0.037
Guidance 0.39 0.22‑0.69 0.001 0.7.50 0.55‑1 0.053
High school 0.62 0.38‑1.02 0.061 0.71 0.54‑0.93 0.016
University Reference 1 ‑ 1 1 ‑
Smoking 0.90 0.74‑1.09 0.291 1.33 1.17‑1.50 0.001
Diabetes 1.06 0.86‑1.30 0.551 1.10 0.96‑1.27 0.159
Hypertension 0.60 0.50‑0.72 0.001 0.95 0.83‑1.08 0.461
High cholesterol 0.77 0.63‑0.95 0.016 0.91 0.78‑1.07 0.301
Chest pain 7.02 5.42‑9 0.001 3.72 3.27‑4.25 0.001
Lack of 
thrombolytic 
therapy
3.02 2.5‑3.64 0.001 2.98 2.64‑3.36 0.001
RBBB 0.54 0.26‑1.09 0.09 3.24 2.26‑4.63 0.001
VT 2.17 1.6‑2.90 0.001 1.98 1.61‑2.43 0.001
STEMI 2.39 1.97‑2.90 0.001 4.29 3.80‑4.86 0.001
PCI 0.88 0.57‑1.35 0.565 0.57 0.42‑0.78 0.001
CABG 0.68 0.45‑1.02 0.063 1.35 0.91‑1.99 0.126
Heart failure 2.2 1.66‑2.91 0.001 1.38 1.15‑1.65 0.001
OR=Odds ratio; CI=Confidence interval; RBBB=Right bundle branch block; 
VT=Ventricular tachycardia; STEMI=ST‑segment elevation myocardial infarction; 
PCI=Percutaneous coronary intervention; CABG=Coronary artery bypass grafting
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in Italy compared with Iran. In a study in Iran, losing the 
golden time to start thrombolytic therapy, lack of beds in 
the Intensive Care Units, and failure to afford the facilities 
and services were some of the obstacles to initiating the 
treatment in stroke and MI patients.[14] In Iran, MI patients 
with stroke history appear to control and mitigate the risk 
factors themselves.[18,24] Our study is the first report in Iran 
and indicated that the pattern of determinants of hospital MI 
mortality with and without a stroke is various. Therefore, 
adopting an appropriate strategy for the treatment and 
prevention of death in the two groups of the patients 
requires close attention to the characteristics of each group 
of the patients. In addition, our study demonstrated that 
the risk factors including hypertension, diabetes, smoking, 
dyslipidemia, and heart failure were more prevalent in MI 
patients with stroke history than those without. MI patients 
without stroke history appear to control and mitigate the 
risk factors themselves. Therefore, it is recommended to give 
greater priority to the MI patients with the previous stroke 
over those without in Iran for training, healthcare, and 
control of the risk factors such as hypertension, diabetes, 
and smoking to enhance the cost‑effectiveness of the 
interventions for prevention and treatment and to prevent 
avoidable mortalities. As no similar study was found to 
make a closer comparison between our and others’ findings, 
similar studies in other countries are needed to confirm the 
present study findings.
Limitations of the study
In this study only the MI patients who died in hospital were 
investigated. Hence, the findings can be generalized only 
to hospitalized patients. In addition, tissue plasminogen 
activator thrombolytic therapy was not considered in MI 
patients with the previous stroke. We did not gather any 
treatment information about these patients before MI. 
Because no similar study, to the best of our knowledge, was 
found to compare our and others’ findings more closely, 
similar studies in other countries should be conducted to 
give more definite explanations.
CONCLUSION
We used a large‑scale database in Iran. Our study 
demonstrated that the risk factors including hypertension, 
diabetes, smoking, dyslipidemia, and heart failure were 
more prevalent in the MI patients with a stroke history than 
those without. In fact, the MI patients without stroke history 
appear to control and mitigate the risk factors themselves. 
Chest pain resistant to treatment gave the highest adjusted 
OR of hospital mortality in patients with stroke followed by 
no thrombolytic therapy and STEMI. It is recommended to 
give greater priority to the MI patients with the previous 
stroke over those without in Iran for training, healthcare, 
and control of the risk factors as well as to enhance the 
cost‑effectiveness of the interventions for prevention and 
treatment.
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